Atorvastatin therapy may have antithrombotic effect in Type 1 diabetes

Thursday, August 5th, 2010

Source: MedWire News Atorvastatin increases fibrin network permeability and may therefore have an antithrombotic effect in patients with Type 1 diabetes, a Swedish study suggests. In the journal├é┬áThrombosis Research, Sara Tehrani, from Danderyd Hospital in Stockholm, and colleagues say: “Atorvastatin therapy potentially has antithrombotic effects that are unrelated to the lipid-lowering effects of the drug, […]

Atorvastatin Appears To Trump Rosuvastatin In Protecting Diabetic, Nondiabetic Kidney Function.

Tuesday, July 6th, 2010

Medscape (7/2, Keller) reported that new research coming out of the Netherlands has “found atorvastatin (ATV) protective and rosuvastatin (RSV) unprotective, and possibly harmful, in diabetic and nondiabetic patients.” In fact, “high-dose ATV significantly reduced proteinuria and did not affect renal function, whereas RSV was associated with a significant decline in function and had no […]

Moderate-dose atorvastatin aids coronary regeneration after AMI

Monday, May 17th, 2010

Source: MedWire News Atorvastatin therapy in patients with acute myocardial infarction (AMI) is associated with a dose-dependent improvement in coronary flow reserve (CFR), study findings indicate. The research, by a Korean team, showed that this effect was driven by mobilization of circulating angiogenic cells together with a suppression of inflammatory cytokines and low-density lipoprotein (LDL) […]